Tenet Healthcare (NYSE:THC) Announces Quarterly Earnings Results

Tenet Healthcare (NYSE:THCGet Free Report) announced its earnings results on Wednesday. The company reported $3.44 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.49, Zacks reports. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%. Tenet Healthcare updated its FY 2025 guidance to 11.740-12.840 EPS.

Tenet Healthcare Stock Performance

Tenet Healthcare stock traded down $8.73 during mid-day trading on Wednesday, hitting $130.10. 1,647,157 shares of the company’s stock traded hands, compared to its average volume of 1,064,176. Tenet Healthcare has a one year low of $86.90 and a one year high of $171.20. The company has a market cap of $12.37 billion, a PE ratio of 4.17, a price-to-earnings-growth ratio of 0.63 and a beta of 2.05. The firm has a 50 day moving average price of $133.85 and a 200 day moving average price of $148.52. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 2.35.

Wall Street Analysts Forecast Growth

THC has been the subject of a number of recent analyst reports. Wells Fargo & Company downgraded shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and decreased their price target for the stock from $205.00 to $150.00 in a research report on Monday, November 25th. Barclays boosted their target price on shares of Tenet Healthcare from $171.00 to $190.00 and gave the stock an “overweight” rating in a research report on Friday, November 8th. JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a $175.00 price target on shares of Tenet Healthcare in a research report on Tuesday, December 17th. UBS Group upped their price objective on Tenet Healthcare from $197.00 to $217.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. Finally, Royal Bank of Canada lifted their target price on Tenet Healthcare from $174.00 to $183.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Three equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $165.00.

View Our Latest Stock Analysis on THC

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Further Reading

Earnings History for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.